Craniopharyngioma: Modern concepts in pathogenesis and treatment

Current Opinion in Pediatrics

Volumn 19, Issue 4, 2007, Pages 471-479

  Garrè, Maria Luisa ^a   Cama, Armando ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Children; Craniopharyngioma; Multidisciplinary approach; Pathogenesis; Quality of life

Indexed keywords

AGE DISTRIBUTION; BENIGN TUMOR; BLOOD VESSEL INJURY; BRAIN TUMOR; CANCER INHIBITION; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CRANIOPHARYNGIOMA; DECOMPRESSION SURGERY; EMBRYO DEVELOPMENT; GENE CONTROL; HEADACHE; HISTOLOGY; HUMAN; INTRACRANIAL PRESSURE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; STEREOTAXIC SURGERY; TUMOR RECURRENCE; TUMOR VOLUME; VISUAL DISORDER;

ADENOMA; ALGORITHMS; CHILD; CRANIOPHARYNGIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; PATIENT CARE TEAM; PITUITARY NEOPLASMS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 34447548647     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3282495a22     Document Type: Review

References (58)

1. Yasargil MG, Curcic M, Kis M, et al. Total removal of craniopharyngiomas: approaches and long-term results in 144 patients. J Neurosurg 1990; 73:3-11.
2. Hoffman HJ, De Silva M, Humphreys RP, et al. Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 1992; 76:47-52.
3. Rajan B, Ashley S, Groman C, et al. Craniopharyngioma: long term results following limited surgery and radiotherapy. Radiother Oncol 1993; 26:1-10.
4. De Vile C, Grant DB, Kendall BE, et al. Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? J Neurosurg 1996; 85:73-81.
5. De Vile CJ, Grant DB, Hayward RD, Stanhope R. Growth and endocrine sequelae of craniopharyngioma. Arch Dis Child 1996; 75:108-114.
6. De Vile CJ, Grant DB, Hayward RD, et al. Hyperphagia and obesity in childhood craniopharyngioma: relation to postoperative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab 1996; 81:2734-2737.
7. Habrand JL, Ganry O, Couanet D, et al. The role of radiation therapy in the management of craniopharyngioma: a 25 year experience and review of the literature. Int J Radiat Oncol Biol Phys 1999; 44:255-263.
8. Merchant TE, Kiehna EN, Sanford RA, et al. Craniopharyngioma: the St Jude children's research hospital experience 1984-2001. Int J Rad Oncol Biol Phys 2002; 53:533-542.
9. Poretti A, Grotzer MA, Ribi K, et al. Outcome of craniopharyngioma in children: long term complications and quality of life. Dev Med Child Neurol 2004; 46:220-229.
10. Hayward RD, Devile C, Brada M. Craniopharyngioma. In: Walker DA, Perilongo G, Punt JAG, Taylor RE, editors. Brain and spinal tumors of childhood. London: Arnold; 2004. pp. 370-386.
11. Sands SA, Milner JS, Goldberg J, et al. Quality of life and behavioural follow-up study of pediatric survivors of craniopharyngioma. J Neurosurg (Pediatrics 4) 2005; 103:302-311.
12. Bunin GR, Surawicz TS, Witman PA, et al. The descriptive epidemiology of craniopharyngioma. Neurosurg Focus 1997; 3 (6):e1.
13. Haupt R, Magnani C, Pavanello M, et al. Epidemiological aspects of craniopharyngioma. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):289-293. This article delineates the causes of lack of sufficient descriptive epidemiological studies on craniopharyngioma, incidence data from different cancer registries and data on improved survival derived from population-based registries.
14. Wellons JC 3rd, Tubbs RS. Staged surgical treatment of a giant neonatal craniopharyngioma: case illustration. J Neurosurg 2006; 105 (1 Suppl):76.
15. Karavitaki N, Cudlip S, Adams CBT, Wass JAH. Craniopharyngiomas. Endocrine Rev 2006; 27:371-397. This is a systematic, very complete review concerning clinical management and treatment of craniopharyngiomas; pathogenesis and pathology aspects are also very well illustrated, as well as differences between adult and paediatric craniopharyngiomas.
16. Nozza P, Gambini C. Paediatric craniopharyngioma: a pathological review. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):295-298.
17. Sartoretti-Schefer S, Wichmann W, Aguzzi A, Valvanis A. MR differentiation of adamantinous and squamous-papillary craniopharyngiomas. AJNR Am J Neuroradiol 1997; 18:77-87.
18. Puget S, Garnett M, Wray A, et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 2007; 106 (1 Suppl):3-12. Puget and co-workers present one of the largest surgical paediatric series well representing the evolving concepts in treatment of craniopharyngiomas from a 'surgical-oriented approach' to an approach tailored to a specific risk factor (involvement of hypothalamus identified preoperatively on imaging). Another issue raised by this article is the need for expertise in centres treating this complex disease and the need for a multidisciplinary approach.
19. Karavitaki N, Brufani C, Warner JT, et al. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol 2005; 62:397-409.
20. Gupta DK, Ojha BK, Sarkar C, et al. Recurrence in craniopharyngiomas: analysis of clinical and histological features. J Clin Neurosci 2006; 13:438-442. Concepts on prognostic factors are evolving in craniopharyngiomas. There are not too many articles clearly addressing the issue of prognostic impact of clinical and histological features. Within the clinical parameters examined in this paper, tumour size (>4 cm) and cystic tumour are the worse prognostic factors for recurrence.
21. Sato K, Oka H, Utsuki S, et al. Ciliated craniopharyngioma may arise from Rathke cleft cyst. Clin Neuropathol 2006; 25:25-28.
22. Powers CJ, New KC, Mc Lendon RE, et al. Cerebellopontine angle craniopharyngioma: a case report and literature review. Pediatr Neurosurg 2007; 43:158-163.
23. Hassanein AM, Glanz SM, Kessler HP, et al. β-catenin is expressed aberrantly in tumours expressing shadow cells. Am J Clin Pathol 2003; 120:732-736.
24. Kato K, Nakatani Y, Kanno H, et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 2004; 203:814-821.
25. Oikonomou E, Barreto DC, Soares B, et al. β-Catenin mutations in craniopharyngiomas and pituitary adenomas. J Neurooncol 2005; 73:205-209.
26. Hofmann B, Kreutzer J, Saeger W, et al. Nuclear [beta]-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngioma and Rathke cleft cyst: a clinico-pathologic approach. Am J Surg Path 2006; 30:1595-1603. This study confirms in a large number of cases the role of a new marker, β-catenin, in the differential diagnosis of craniopharyngioma with Rathke cleft cyst and it adds insight into the pathogenetic mechanisms of these diseases.
27. Takuma N, Sheng HZ, Furuta Y, Ward JM, et al. Formation of Rathke's pouch requires dual induction from the diencephalons. Development 1998; 125:4835-4840.
28. Nascif SO, Vieira TC, Ramos-Dias JC, et al. Waxing and waning of a pituitary mass in a young woman with combined pituitary hormone deficiency (CPHD) due to a PROP-1 mutation. Pituitary 2006; 9:47-52.
29. Al-Braim NYY, Asa SL. My approach to pathology of the pituitary gland. J Clin Pathol 2006; 59:1245-1253.
30. Merchant TE, Kiehna EN, Kun LE, et al. Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J Neurosurg 2006; 104 (2 Suppl):94-102. This article demonstrates that conformal radiation therapy is currently the best radiation technique for children and its impact on longitudinal IQ is not so relevant for QoL. Furthermore, it gives evidence on the role of surgery-related factors on IQ decline. Technical difficulties and failures of this high-precision technique are discussed in detail.
31. Defoort-Dhellemmes S, Moritz F, Bouacha I, Vinchon M. Craniopharyngioma: ophthalmological aspects at diagnosis. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):321-324. There are very few papers in the literature discussing the usefulness and methods of a correct ophthalmologic evaluation at diagnosis and its impact on surgical approach. The practical recommendations are based on data referring to a paediatric series of 29 children diagnosed at a large institution in France.
32. Di Rocco C, Caldarelli M, Tamburrini G, Massimi L. Surgical management of craniopharyngiomas: experience with a pediatric series. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):355-366.
33. Di Battista E, Naselli A, Queirolo S, et al. Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):431-437.
34. Hopper N, Albanese A, Ghirardello S, Maghnie M. The preoperative endocrine assessment of craniopharyngiomas. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):325-327. Preoperative endocrine evaluation is fundamental for the treatment of and surgical decisions in craniopharyngiomas as information from imaging should also be supported by clinical data on hypothalamic impairment at presentation, before surgery. This paper gives guidelines for such an approach.
35. Rossi A, Cama A, Consales A, et al. Neuroimaging of pediatric craniopharyngiomas: a pictorial essay. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):299-319. Identification of vital structures disrupted or deformed by craniopharyngiomas is the cornerstone of this modern approach to this disease, aiming to tailor surgical approach to specific risk factors for postsurgery dysfunction. The author is depicting a rich number of images that illustrate these modern concepts.
36. Rennert J, Doerfler A. Imaging of sellar and parasellar lesions. Clin Neurol Neurosurg 2007; 109:111-124.
37. Spoudeas HA, Saran F, Pizer B. A multimodality approach to the treatment of craniopharyngiomas avoiding hypothalamic morbidity: a UK perspective. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):447-451. This is one of the first papers to report on a common national strategy (in the UK) for children with craniopharyngiomas; their philosophy is also to use age and size of tumour as prognostic factors.
38. Dhellemmes P, Vinchon M. Radical resection for craniopharyngiomas in children: surgical technique and clinical results. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):329-335. The authors give a clear and well documented picture of all the different surgical approaches available for direct surgery in craniopharyngiomas with detailed explanations of the advantages and problems based on a large experience of 48 cases operated on at a single large institution in France from 1981 to 2003. Limits of resection and treatment at recurrence are also discussed.
39. Dekkers OM, Biermasz NR, Smit JW, et al. Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol 2006; 154:483-489. There are very few papers on the evaluation of QoL of adults with craniopharyngioma. This paper increases our scarce knowledge on the long-term follow up of adult craniopharyngioma.
40. Habrand JL, Saran F, Alapetite C, et al. Radiation therapy in the management of craniopharyngioma: current concepts and future developments. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):389-394.
41. Baumbert BG, Norton IA, Lomax AJ, Davis JB. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensitymodulated proton beams for intracranial lesions. Int J Radiat Oncol Biol Phys 2004; 60:1314-1324.
42. Luu QT, Loredo LN, Archambeau JO, et al. Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report. J Cancer 2006; 12:155-159.
43. Fitzek MM, Linggood RM, Adams J, Munzenrider JE. Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at Harvard cyclotron laboratory and Massachusetts General Hospital. Int J Radiat Oncol Biol Phys 2006; 64:1348-1354. This is one of the first reports on the efficacy of proton therapy in patients with craniopharyngioma. It includes a series of 15 patients followed for a period of 13 years. It shows that for external beam radiotherapy and CSRT, although 5-year survival is high (92%), overall survival continues to decline, never reaching a plateau.
44. Ghirardello S, Hopper N, Albanese A, Maghnie M. Diabetes insipidus in craniopharyngioma: postoperative management of water and electrolyte disorders. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):413-421.
45. Muller HL, Muller-Stover S, Gebhardt U, et al. Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):423-429.
46. Muller HL, Handwerler G, Gebhard U, et al. Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness. Cancer Causes Control 2006; 17:583-589. Although modern treatment of craniopharyngioma is intended to avoid as much as possible severe hypothalamic damage due to surgery, a certain number of patients are affected by this severe condition. This article presents interesting results on endocrine research, demonstrating that melatonin therapy can significantly help patients with daytime sleepiness and that this helps in controlling obesity.
47. Scarzello G, Buzzaccarini MS, Perilongo G, et al. Acute and late morbidity after limited resection and focal radiation therapy in craniopharyngiomas. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):399-405.
48. Minniti G, Saran F, Traish D, et al. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother Oncol 2007; 82:90-95.
49. Kiehna EN, Mulhern RK, Li C, et al. Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy. J Clin Oncol 2006; 24:5283-5290.
50. Karavitaki N, Warner JT, Marland A, et al. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. Clin Endocrinol (Oxf) 2006; 64:556-560.
51. Zona G, Spaziante R. Management of cystic craniopharyngiomas in childhood by a transsphenoidal approach. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):381-388. This paper deals with the conservative treatment of cystic craniopharyngioma in children and adults. The transsphenoidal approach, well known by the authors who are pituitary surgeons, is also demonstrated to be useful and safe in the conservative treatment of children. A relevant discussion on the characteristics of cystic craniopharyngioma is also reported.
52. Szeifert GT, Balint K, Sipos L, et al. Pathological findings in cystic craniopharyngiomas after stereotactic intracavitary irradiation with yttrium-90 isotope. Prog Neurol Surg 2007; 20:297-302.
53. Julow J, Lanyi F, Hajda M, et al. Stereotactic intracavitary irradiation of cystic craniopharyngiomas with yttrium-90 isotope. Prog Neurol Surg 2007; 20:289-296.
54. Kim SD, Park JY, Park J, et al. Radiological findings following postsurgical intratumoral bleomycin injection for cystic craniopharyngioma. Clin Neurol Neurosurg 2007; 109:236-241.
55. Frank G, Pasquini E, Doglietto F, et al. The endoscopic extended transsphenoidal approach for craniopharyngiomas. Neurosurgery 2006; 59 (1 Suppl 1):ONS75-ONS83.
56. Cama A, Ravegnani M, Piatelli G, et al. Conservative surgical approach in treatment strategy of craniopharyngioma: experience at a single institution in Italy. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):337-340.
57. Boop FA. Craniopharyngioma. J Neurosurg 2007; 106 (1 Suppl):1-2; discussion 2.
58. Muller HL, Albanese A, Calaminus G, et al. Consensus and perspectives on treatment strategies in childhood craniopharyngioma: results of a meeting of the Craniopharyngioma Study Group (SIOP), Genova, 2004. J Pediatr Endocrinol Metab 2006; 19 (Suppl 1):453-454.